{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T03:33:03Z","timestamp":1768447983317,"version":"3.49.0"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,1,25]],"date-time":"2022-01-25T00:00:00Z","timestamp":1643068800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,1,25]],"date-time":"2022-01-25T00:00:00Z","timestamp":1643068800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Ductal carcinoma in situ (DCIS) of breast is the noninvasive lesion that has propensity to progress to the malignant form. At present, it is still unknown which lesions can potentially progress to invasive forms. In this study, we aimed to identify key lncRNAs involved in DCIS growth.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>We employ disease-related lncProfiler array to identify IPW in specimens of DCIS and matching control samples and validate the observations in three DCIS-non-tumorigenic cell lines. Further, we examine the mechanism of IPW action and the downstream signaling in in vitro and in vivo assays. Importantly, we screened a library containing 390 natural compounds to identify candidate compound selectively inhibiting IPW low DCIS cells.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>We identified lncRNA IPW as a novel tumor suppressor critical for inhibiting DCIS growth. Ectopic expression of IPW in DCIS cells strongly inhibited cell proliferation, colony formation and cell cycle progression while silencing IPW in primary breast cells promoted their growth. Additionally, orthotropic implantation of cells with ectopic expression of IPW exhibited decreased tumor growth in vivo. Mechanistically, IPW epigenetically enhanced miR-29c expression by promoting H3K4me3 enrichment in its promoter region. Furthermore, we identified that miR-29c negatively regulated a stemness promoting gene, ID2, and diminished self-renewal ability of DCIS cells. Importantly, we screened a library containing 390 natural compounds and identified toyocamycin as a compound that selectively inhibited the growth of DCIS with low expression of IPW, while it did not affect DCIS with high IPW expression. Toyocamycin also suppressed genes associated with self-renewal ability and inhibited DCIS growth in vivo.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>Our findings revealed a critical role of the IPW-miR-29c-ID2 axis in DCIS formation and suggested potential clinical use of toyocamycin for the treatment of DCIS.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13058-022-01504-4","type":"journal-article","created":{"date-parts":[[2022,1,25]],"date-time":"2022-01-25T05:30:50Z","timestamp":1643088650000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["LncRNA IPW inhibits growth of ductal carcinoma in situ by downregulating ID2 through miR-29c"],"prefix":"10.1186","volume":"24","author":[{"given":"Ravindra Pramod","family":"Deshpande","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sambad","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Puspa Raj","family":"Pandey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xinhong","family":"Pei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kerui","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shih-Ying","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abhishek","family":"Tyagi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dan","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yin-Yuan","family":"Mo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kounosuke","family":"Watabe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,1,25]]},"reference":[{"issue":"41","key":"1504_CR1","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1093\/jncimonographs\/lgq035","volume":"2010","author":"DC Allred","year":"2010","unstructured":"Allred DC. Ductal carcinoma in situ: terminology, classification, and natural history. J Natl Cancer Inst Monogr. 2010;2010(41):134\u20138.","journal-title":"J Natl Cancer Inst Monogr"},{"issue":"7","key":"1504_CR2","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1200\/JCO.2014.57.9029","volume":"33","author":"B McCormick","year":"2015","unstructured":"McCormick B, Winter K, Hudis C, Kuerer HM, Rakovitch E, Smith BL, Sneige N, Moughan J, Shah A, Germain I, et al. RTOG 9804: a prospective randomized trial for good-risk ductal carcinoma in situ comparing radiotherapy with observation. J Clin Oncol. 2015;33(7):709\u201315.","journal-title":"J Clin Oncol"},{"key":"1504_CR3","doi-asserted-by":"publisher","first-page":"100241","DOI":"10.1016\/j.ctarc.2020.100241","volume":"26","author":"M Co","year":"2021","unstructured":"Co M, Lee A, Kwong A. Non-surgical treatment for ductal carcinoma in situ of the breasts - a prospective study on patient\u2019s perspective. Cancer Treat Res Commun. 2021;26:100241.","journal-title":"Cancer Treat Res Commun"},{"key":"1504_CR4","doi-asserted-by":"publisher","first-page":"192","DOI":"10.3389\/fonc.2017.00192","volume":"7","author":"Y Sagara","year":"2017","unstructured":"Sagara Y, Julia W, Golshan M, Toi M. Paradigm shift toward reducing overtreatment of ductal carcinoma in situ of breast. Front Oncol. 2017;7:192.","journal-title":"Front Oncol"},{"issue":"1","key":"1504_CR5","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1038\/ng0503-23a","volume":"34","author":"IJ Fidler","year":"2003","unstructured":"Fidler IJ, Kripke ML. Genomic analysis of primary tumors does not address the prevalence of metastatic cells in the population. Nat Genet. 2003;34(1):23.","journal-title":"Nat Genet"},{"key":"1504_CR6","doi-asserted-by":"crossref","unstructured":"Carraro DM, Elias EV, Andrade VP. Ductal carcinoma in situ of the breast: morphological and molecular features implicated in progression. Biosci Rep 2014;34(1).","DOI":"10.1042\/BSR20130077"},{"key":"1504_CR7","first-page":"23","volume":"2","author":"M Morlando","year":"2015","unstructured":"Morlando M, Ballarino M, Fatica A. Long non-coding RNAs: new players in Hematopoiesis and Leukemia. Front Med (Lausanne). 2015;2:23.","journal-title":"Front Med (Lausanne)"},{"issue":"1","key":"1504_CR8","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.bbagrm.2015.08.009","volume":"1859","author":"AJ Blythe","year":"2016","unstructured":"Blythe AJ, Fox AH, Bond CS. The ins and outs of lncRNA structure: how, why and what comes next? Biochim Biophys Acta. 2016;1859(1):46\u201358.","journal-title":"Biochim Biophys Acta"},{"issue":"9","key":"1504_CR9","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1016\/j.tibs.2016.07.003","volume":"41","author":"LL Chen","year":"2016","unstructured":"Chen LL. Linking long noncoding RNA localization and function. Trends Biochem Sci. 2016;41(9):761\u201372.","journal-title":"Trends Biochem Sci"},{"key":"1504_CR10","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1007\/978-981-10-5203-3_2","volume":"1008","author":"VS Akhade","year":"2017","unstructured":"Akhade VS, Pal D, Kanduri C. Long noncoding RNA: genome organization and mechanism of action. Adv Exp Med Biol. 2017;1008:47\u201374.","journal-title":"Adv Exp Med Biol"},{"issue":"23","key":"1504_CR11","doi-asserted-by":"publisher","first-page":"9148","DOI":"10.1158\/0008-5472.CAN-09-1043","volume":"69","author":"C Jedeszko","year":"2009","unstructured":"Jedeszko C, Victor BC, Podgorski I, Sloane BF. Fibroblast hepatocyte growth factor promotes invasion of human mammary ductal carcinoma in situ. Cancer Res. 2009;69(23):9148\u201355.","journal-title":"Cancer Res"},{"key":"1504_CR12","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1007\/978-1-62703-125-7_13","volume":"945","author":"PA Vidi","year":"2013","unstructured":"Vidi PA, Bissell MJ, Leli\u00e8vre SA. Three-dimensional culture of human breast epithelial cells: the how and the why. Methods Mol Biol. 2013;945:193\u2013219.","journal-title":"Methods Mol Biol"},{"issue":"1","key":"1504_CR13","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1007\/s10549-018-05126-3","volume":"175","author":"Y Liu","year":"2019","unstructured":"Liu Y, Pandey PR, Sharma S, Xing F, Wu K, Chittiboyina A, Wu SY, Tyagi A, Watabe K. ID2 and GJB2 promote early-stage breast cancer progression by regulating cancer stemness. Breast Cancer Res Treat. 2019;175(1):77\u201390.","journal-title":"Breast Cancer Res Treat"},{"issue":"1","key":"1504_CR14","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1007\/s10549-017-4644-3","volume":"169","author":"SA Narod","year":"2018","unstructured":"Narod SA, Sopik V. Is invasion a necessary step for metastases in breast cancer? Breast Cancer Res Treat. 2018;169(1):9\u201323.","journal-title":"Breast Cancer Res Treat"},{"issue":"2","key":"1504_CR15","doi-asserted-by":"publisher","first-page":"150","DOI":"10.5317\/wjog.v5.i2.150","volume":"5","author":"PK Lo","year":"2016","unstructured":"Lo PK, Wolfson B, Zhou Q. Cancer stem cells and early stage basal-like breast cancer. World J Obstet Gynecol. 2016;5(2):150\u201361.","journal-title":"World J Obstet Gynecol"},{"key":"1504_CR16","doi-asserted-by":"crossref","unstructured":"Fridrichova I, Zmetakova I. MicroRNAs contribute to breast cancer invasiveness. Cells 2019;8(11).","DOI":"10.3390\/cells8111361"},{"issue":"2","key":"1504_CR17","doi-asserted-by":"publisher","first-page":"188413","DOI":"10.1016\/j.bbcan.2020.188413","volume":"1874","author":"A Kandettu","year":"2020","unstructured":"Kandettu A, Radhakrishnan R, Chakrabarty S, Sriharikrishnaa S, Kabekkodu SP. The emerging role of miRNA clusters in breast cancer progression. Biochim Biophys Acta Rev Cancer. 2020;1874(2):188413.","journal-title":"Biochim Biophys Acta Rev Cancer"},{"key":"1504_CR18","doi-asserted-by":"publisher","first-page":"526850","DOI":"10.3389\/fonc.2020.526850","volume":"10","author":"SR Volovat","year":"2020","unstructured":"Volovat SR, Volovat C, Hordila I, Hordila DA, Mirestean CC, Miron OT, Lungulescu C, Scripcariu DV, Stolniceanu CR, Konsoulova-Kirova AA, et al. MiRNA and LncRNA as potential biomarkers in triple-negative breast cancer: a review. Front Oncol. 2020;10:526850.","journal-title":"Front Oncol"},{"issue":"4","key":"1504_CR19","doi-asserted-by":"publisher","first-page":"194378","DOI":"10.1016\/j.bbagrm.2019.04.005","volume":"1863","author":"D Tomar","year":"2020","unstructured":"Tomar D, Yadav AS, Kumar D, Bhadauriya G, Kundu GC. Non-coding RNAs as potential therapeutic targets in breast cancer. Biochim Biophys Acta Gene Regul Mech. 2020;1863(4):194378.","journal-title":"Biochim Biophys Acta Gene Regul Mech"},{"issue":"5992","key":"1504_CR20","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1126\/science.1192002","volume":"329","author":"MC Tsai","year":"2010","unstructured":"Tsai MC, Manor O, Wan Y, Mosammaparast N, Wang JK, Lan F, Shi Y, Segal E, Chang HY. Long noncoding RNA as modular scaffold of histone modification complexes. Science. 2010;329(5992):689\u201393.","journal-title":"Science"},{"issue":"9","key":"1504_CR21","doi-asserted-by":"publisher","first-page":"eaao2110","DOI":"10.1126\/sciadv.aao2110","volume":"3","author":"Y Long","year":"2017","unstructured":"Long Y, Wang X, Youmans DT, Cech TR. How do lncRNAs regulate transcription? Sci Adv. 2017;3(9):eaao2110.","journal-title":"Sci Adv"},{"issue":"4","key":"1504_CR22","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1016\/j.cell.2007.05.009","volume":"129","author":"A Barski","year":"2007","unstructured":"Barski A, Cuddapah S, Cui K, Roh TY, Schones DE, Wang Z, Wei G, Chepelev I, Zhao K. High-resolution profiling of histone methylations in the human genome. Cell. 2007;129(4):823\u201337.","journal-title":"Cell"},{"issue":"3","key":"1504_CR23","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1038\/ng1966","volume":"39","author":"ND Heintzman","year":"2007","unstructured":"Heintzman ND, Stuart RK, Hon G, Fu Y, Ching CW, Hawkins RD, Barrera LO, Van Calcar S, Qu C, Ching KA, et al. Distinct and predictive chromatin signatures of transcriptional promoters and enhancers in the human genome. Nat Genet. 2007;39(3):311\u20138.","journal-title":"Nat Genet"},{"issue":"2","key":"1504_CR24","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.cell.2005.01.001","volume":"120","author":"BE Bernstein","year":"2005","unstructured":"Bernstein BE, Kamal M, Lindblad-Toh K, Bekiranov S, Bailey DK, Huebert DJ, McMahon S, Karlsson EK, Kulbokas EJ 3rd, Gingeras TR, et al. Genomic maps and comparative analysis of histone modifications in human and mouse. Cell. 2005;120(2):169\u201381.","journal-title":"Cell"},{"issue":"3","key":"1504_CR25","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1158\/1541-7786.MCR-14-0389","volume":"13","author":"T Salz","year":"2015","unstructured":"Salz T, Deng C, Pampo C, Siemann D, Qiu Y, Brown K, Huang S. Histone methyltransferase hSETD1A is a novel regulator of metastasis in breast cancer. Mol Cancer Res. 2015;13(3):461\u20139.","journal-title":"Mol Cancer Res"},{"issue":"11","key":"1504_CR26","doi-asserted-by":"publisher","first-page":"E1016","DOI":"10.1073\/pnas.1215768110","volume":"110","author":"PF South","year":"2013","unstructured":"South PF, Harmeyer KM, Serratore ND, Briggs SD. H3K4 methyltransferase Set1 is involved in maintenance of ergosterol homeostasis and resistance to Brefeldin A. Proc Natl Acad Sci U S A. 2013;110(11):E1016-1025.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"12","key":"1504_CR27","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.1038\/cr.2008.309","volume":"18","author":"X Liu","year":"2008","unstructured":"Liu X, Huang J, Chen T, Wang Y, Xin S, Li J, Pei G, Kang J. Yamanaka factors critically regulate the developmental signaling network in mouse embryonic stem cells. Cell Res. 2008;18(12):1177\u201389.","journal-title":"Cell Res"},{"key":"1504_CR28","doi-asserted-by":"publisher","first-page":"715","DOI":"10.5604\/17322693.1107325","volume":"68","author":"\u0141 Fu\u0142awka","year":"2014","unstructured":"Fu\u0142awka \u0141, Donizy P, Ha\u0142o\u0144 A. Yamanaka\u2019s factors and core transcription factors\u2013the molecular link between embryogenesis and carcinogenesis. Postepy Hig Med Dosw (Online). 2014;68:715\u201321.","journal-title":"Postepy Hig Med Dosw (Online)"},{"issue":"7","key":"1504_CR29","doi-asserted-by":"publisher","first-page":"3983","DOI":"10.1073\/pnas.0530291100","volume":"100","author":"M Al-Hajj","year":"2003","unstructured":"Al-Hajj M, Wicha MS, Benito-Hernandez A, Morrison SJ, Clarke MF. Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci U S A. 2003;100(7):3983\u20138.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"18","key":"1504_CR30","doi-asserted-by":"publisher","first-page":"14428","DOI":"10.18632\/oncotarget.24467","volume":"9","author":"Y Tanabe","year":"2018","unstructured":"Tanabe Y, Suehara Y, Kohsaka S, Hayashi T, Akaike K, Mukaihara K, Kurihara T, Kim Y, Okubo T, Ishii M, et al. IRE1\u03b1-XBP1 inhibitors exerted anti-tumor activities in Ewing\u2019s sarcoma. Oncotarget. 2018;9(18):14428\u201343.","journal-title":"Oncotarget"},{"issue":"7","key":"1504_CR31","doi-asserted-by":"publisher","first-page":"e79","DOI":"10.1038\/bcj.2012.26","volume":"2","author":"M Ri","year":"2012","unstructured":"Ri M, Tashiro E, Oikawa D, Shinjo S, Tokuda M, Yokouchi Y, Narita T, Masaki A, Ito A, Ding J, et al. Identification of Toyocamycin, an agent cytotoxic for multiple myeloma cells, as a potent inhibitor of ER stress-induced XBP1 mRNA splicing. Blood Cancer J. 2012;2(7):e79.","journal-title":"Blood Cancer J"},{"issue":"6","key":"1504_CR32","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1038\/ng.2968","volume":"46","author":"Y Stelzer","year":"2014","unstructured":"Stelzer Y, Sagi I, Yanuka O, Eiges R, Benvenisty N. The noncoding RNA IPW regulates the imprinted DLK1-DIO3 locus in an induced pluripotent stem cell model of Prader-Willi syndrome. Nat Genet. 2014;46(6):551\u20137.","journal-title":"Nat Genet"},{"issue":"8","key":"1504_CR33","first-page":"1687","volume":"13","author":"J Rachmilewitz","year":"1996","unstructured":"Rachmilewitz J, Elkin M, Looijenga LH, Verkerk AJ, Gonik B, Lustig O, Werner D, de Groot N, Hochberg A. Characterization of the imprinted IPW gene: allelic expression in normal and tumorigenic human tissues. Oncogene. 1996;13(8):1687\u201392.","journal-title":"Oncogene"},{"issue":"2","key":"1504_CR34","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1067\/mpd.2003.81","volume":"142","author":"HD Davies","year":"2003","unstructured":"Davies HD, Leusink GL, McConnell A, Deyell M, Cassidy SB, Fick GH, Coppes MJ. Myeloid leukemia in Prader-Willi syndrome. J Pediatr. 2003;142(2):174\u20138.","journal-title":"J Pediatr"},{"key":"1504_CR35","unstructured":"Kristiina P, Reijo S, Markus K, Eero P. Cancer incidence among persons Prader-Willi syndrome in Finland. 2008."},{"key":"1504_CR36","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1007\/978-1-4939-3378-5_21","volume":"1402","author":"MD Paraskevopoulou","year":"2016","unstructured":"Paraskevopoulou MD, Hatzigeorgiou AG. Analyzing MiRNA-LncRNA interactions. Methods Mol Biol. 2016;1402:271\u201386.","journal-title":"Methods Mol Biol"},{"issue":"12","key":"1504_CR37","doi-asserted-by":"publisher","first-page":"5768","DOI":"10.1111\/jcmm.13866","volume":"22","author":"Y Huang","year":"2018","unstructured":"Huang Y. The novel regulatory role of lncRNA-miRNA-mRNA axis in cardiovascular diseases. J Cell Mol Med. 2018;22(12):5768\u201375.","journal-title":"J Cell Mol Med"},{"issue":"9","key":"1504_CR38","doi-asserted-by":"publisher","first-page":"1986","DOI":"10.1161\/ATVBAHA.118.311276","volume":"38","author":"MS Hulshoff","year":"2018","unstructured":"Hulshoff MS, Xu X, Krenning G, Zeisberg EM. Epigenetic regulation of endothelial-to-mesenchymal transition in chronic heart disease. Arterioscler Thromb Vasc Biol. 2018;38(9):1986\u201396.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"4","key":"1504_CR39","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1016\/j.ccell.2019.08.008","volume":"36","author":"ML Burr","year":"2019","unstructured":"Burr ML, Sparbier CE, Chan KL, Chan YC, Kersbergen A, Lam EYN, Azidis-Yates E, Vassiliadis D, Bell CC, Gilan O, et al. An evolutionarily conserved function of polycomb silences the MHC class I antigen presentation pathway and enables immune evasion in cancer. Cancer Cell. 2019;36(4):385-401.e388.","journal-title":"Cancer Cell"},{"issue":"4","key":"1504_CR40","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1038\/s41556-020-0494-z","volume":"22","author":"A Sankar","year":"2020","unstructured":"Sankar A, Lerdrup M, Manaf A, Johansen JV, Gonzalez JM, Borup R, Blanshard R, Klungland A, Hansen K, Andersen CY, et al. KDM4A regulates the maternal-to-zygotic transition by protecting broad H3K4me3 domains from H3K9me3 invasion in oocytes. Nat Cell Biol. 2020;22(4):380\u20138.","journal-title":"Nat Cell Biol"},{"issue":"1","key":"1504_CR41","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1186\/s12943-019-1115-y","volume":"18","author":"B Xiu","year":"2019","unstructured":"Xiu B, Chi Y, Liu L, Chi W, Zhang Q, Chen J, Guo R, Si J, Li L, Xue J, et al. LINC02273 drives breast cancer metastasis by epigenetically increasing AGR2 transcription. Mol Cancer. 2019;18(1):187.","journal-title":"Mol Cancer"},{"issue":"1","key":"1504_CR42","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1038\/s41467-017-02431-1","volume":"9","author":"P Neumann","year":"2018","unstructured":"Neumann P, Ja\u00e9 N, Knau A, Glaser SF, Fouani Y, Rossbach O, Kr\u00fcger M, John D, Bindereif A, Grote P, et al. The lncRNA GATA6-AS epigenetically regulates endothelial gene expression via interaction with LOXL2. Nat Commun. 2018;9(1):237.","journal-title":"Nat Commun"},{"key":"1504_CR43","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1007\/978-1-4939-9207-2_14","volume":"1970","author":"D Veneziano","year":"2019","unstructured":"Veneziano D, Marceca GP, Di Bella S, Nigita G, Distefano R, Croce CM. Investigating miRNA-lncRNA interactions: computational tools and resources. Methods Mol Biol. 2019;1970:251\u201377.","journal-title":"Methods Mol Biol"},{"issue":"4","key":"1504_CR44","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1016\/j.cell.2011.09.048","volume":"147","author":"M Cordenonsi","year":"2011","unstructured":"Cordenonsi M, Zanconato F, Azzolin L, Forcato M, Rosato A, Frasson C, Inui M, Montagner M, Parenti AR, Poletti A, et al. The Hippo transducer TAZ confers cancer stem cell-related traits on breast cancer cells. Cell. 2011;147(4):759\u201372.","journal-title":"Cell"},{"issue":"42","key":"1504_CR45","doi-asserted-by":"publisher","first-page":"5111","DOI":"10.1038\/onc.2012.519","volume":"32","author":"PR Pandey","year":"2013","unstructured":"Pandey PR, Xing F, Sharma S, Watabe M, Pai SK, Iiizumi-Gairani M, Fukuda K, Hirota S, Mo YY, Watabe K. Elevated lipogenesis in epithelial stem-like cell confers survival advantage in ductal carcinoma in situ of breast cancer. Oncogene. 2013;32(42):5111\u201322.","journal-title":"Oncogene"},{"issue":"8","key":"1504_CR46","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1158\/1940-6207.CAPR-19-0566","volume":"13","author":"NL Shan","year":"2020","unstructured":"Shan NL, Minden A, Furmanski P, Bak MJ, Cai L, Wernyj R, Sargsyan D, Cheng D, Wu R, Kuo HD, et al. Analysis of the transcriptome: regulation of cancer stemness in breast ductal carcinoma in situ by Vitamin D Compounds. Cancer Prev Res (Phila). 2020;13(8):673\u201386.","journal-title":"Cancer Prev Res (Phila)"},{"key":"1504_CR47","first-page":"10","volume":"2019","author":"LM Martinez","year":"1942","unstructured":"Martinez LM, Robila V, Clark NM, Du W, Idowu MO, Rutkowski MR, Bos PD. Regulatory T cells control the switch from in situ to invasive breast cancer. Front Immunol. 1942;2019:10.","journal-title":"Front Immunol"},{"issue":"6","key":"1504_CR48","doi-asserted-by":"publisher","first-page":"4313","DOI":"10.1074\/jbc.M412614200","volume":"280","author":"H Kurooka","year":"2005","unstructured":"Kurooka H, Yokota Y. Nucleo-cytoplasmic shuttling of Id2, a negative regulator of basic helix-loop-helix transcription factors. J Biol Chem. 2005;280(6):4313\u201320.","journal-title":"J Biol Chem"},{"issue":"5","key":"1504_CR49","doi-asserted-by":"publisher","first-page":"2767","DOI":"10.18632\/oncotarget.3089","volume":"6","author":"J Jiang","year":"2015","unstructured":"Jiang J, Yu C, Chen M, Zhang H, Tian S, Sun C. Reduction of miR-29c enhances pancreatic cancer cell migration and stem cell-like phenotype. Oncotarget. 2015;6(5):2767\u201378.","journal-title":"Oncotarget"},{"key":"1504_CR50","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1186\/s13148-018-0495-y","volume":"10","author":"W Li","year":"2018","unstructured":"Li W, Yi J, Zheng X, Liu S, Fu W, Ren L, Li L, Hoon DSB, Wang J, Du G. miR-29c plays a suppressive role in breast cancer by targeting the TIMP3\/STAT1\/FOXO1 pathway. Clin Epigenetics. 2018;10:64.","journal-title":"Clin Epigenetics"},{"issue":"2","key":"1504_CR51","first-page":"1543","volume":"16","author":"W Zhang","year":"2018","unstructured":"Zhang W, Luo P. MicroRNA-29c restores cisplatin sensitivity in liver cancer through direct inhibition of sirtuin 1 expression. Oncol Lett. 2018;16(2):1543\u201350.","journal-title":"Oncol Lett"},{"key":"1504_CR52","doi-asserted-by":"publisher","first-page":"22966","DOI":"10.1038\/srep22966","volume":"6","author":"HJ Dong","year":"2016","unstructured":"Dong HJ, Jang GB, Lee HY, Park SR, Kim JY, Nam JS, Hong IS. The Wnt\/\u03b2-catenin signaling\/Id2 cascade mediates the effects of hypoxia on the hierarchy of colorectal-cancer stem cells. Sci Rep. 2016;6:22966.","journal-title":"Sci Rep"},{"issue":"12","key":"1504_CR53","doi-asserted-by":"publisher","first-page":"1810","DOI":"10.1038\/bjc.2017.373","volume":"117","author":"WJ Bae","year":"2017","unstructured":"Bae WJ, Koo BS, Lee SH, Kim JM, Rho YS, Lim JY, Moon JH, Cho JH, Lim YC. Inhibitor of DNA binding 2 is a novel therapeutic target for stemness of head and neck squamous cell carcinoma. Br J Cancer. 2017;117(12):1810\u20138.","journal-title":"Br J Cancer"},{"issue":"4","key":"1504_CR54","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1038\/nmeth1015","volume":"4","author":"GY Lee","year":"2007","unstructured":"Lee GY, Kenny PA, Lee EH, Bissell MJ. Three-dimensional culture models of normal and malignant breast epithelial cells. Nat Methods. 2007;4(4):359\u201365.","journal-title":"Nat Methods"},{"issue":"2","key":"1504_CR55","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1007\/s10549-010-1300-6","volume":"130","author":"PR Pandey","year":"2011","unstructured":"Pandey PR, Okuda H, Watabe M, Pai SK, Liu W, Kobayashi A, Xing F, Fukuda K, Hirota S, Sugai T, et al. Resveratrol suppresses growth of cancer stem-like cells by inhibiting fatty acid synthase. Breast Cancer Res Treat. 2011;130(2):387\u201398.","journal-title":"Breast Cancer Res Treat"}],"container-title":["Breast Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13058-022-01504-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13058-022-01504-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13058-022-01504-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,22]],"date-time":"2022-10-22T15:08:54Z","timestamp":1666451334000},"score":1,"resource":{"primary":{"URL":"https:\/\/breast-cancer-research.biomedcentral.com\/articles\/10.1186\/s13058-022-01504-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,25]]},"references-count":55,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["1504"],"URL":"https:\/\/doi.org\/10.1186\/s13058-022-01504-4","relation":{},"ISSN":["1465-542X"],"issn-type":[{"value":"1465-542X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,25]]},"assertion":[{"value":"16 August 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 January 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 January 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the institutional review board of the Wake forest University.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Authors report no conflict of interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"6"}}